Heparin therapy for the renal disease of malignant hypertension.
D000328:Adult; D000743:Anemia, Hemolytic / Q000209:etiology; D003404:Creatinine / Q000097:blood; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006406:Hematoma / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000150:complications / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000209:etiology; D016030:Kidney Transplantation; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D009135:Muscular Diseases / Q000139:chemically induced; D009392:Nephrectomy; D006435:Renal Dialysis; D012166:Retinal Hemorrhage / Q000209:etiology; D014184:Transplantation, Homologous
D006830:Hydralazine; D008750:Methyldopa; D004176:Dipyridamole; D006493:Heparin; D003404:Creatinine; D006145:Guanethidine